Skip to main content
NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
11.90
-0.27 (-2.22%)
At close: Dec 5, 2025, 4:00 PM EST
11.50
-0.40 (-3.36%)
After-hours: Dec 5, 2025, 6:11 PM EST

NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.54 billion as of December 5, 2025. Its market cap has decreased by -21.91% in one year.

Market Cap
1.54B
Enterprise Value
1.79B
1-Year Change
-21.91%
Ranking
#2218
Category
Small-Cap
Stock Price
$11.90

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.54B, an increase of 19,390.06%. That is a compound annual growth rate of 27.45%.

History

DateMarket Cap% Change
Dec 5, 20251.54B-27.21%
Dec 31, 20242.12B2.57%
Dec 29, 20232.06B76.73%
Dec 30, 20221.17B-72.22%
Dec 31, 20214.20B-29.72%
Dec 31, 20205.98B95.74%
Dec 31, 20193.05B160.37%
Dec 31, 20181.17B64.64%
Dec 29, 2017712.40M5.87%
Dec 30, 2016672.90M41.66%
Dec 31, 2015475.00M89.92%
Dec 31, 2014250.10M41.06%
Dec 31, 2013177.30M57.88%
Dec 31, 2012112.30M85.62%
Dec 30, 201160.50M24.49%
Dec 31, 201048.60M-12.90%
Dec 31, 200955.80M189.12%
Dec 31, 200819.30M-43.07%
Dec 31, 200733.90M-16.30%
Dec 29, 200640.50M841.86%
Dec 30, 20054.30M-20.37%
Dec 31, 20045.40M-31.65%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 908.36B
Johnson & Johnson 487.83B
AbbVie 404.22B
UnitedHealth Group 302.09B
AstraZeneca 279.81B
Novartis AG 255.73B
Merck & Co. 250.41B
Abbott Laboratories 218.05B
Market Cap Rankings